All News

In the January 2015 issue we introduced you to 5 of our favorite mobile apps. Here is the second half of our list of top-10 apps that you and your patients will definitely want to try.

Among BRCA mutation carriers, risk-reducing bilateral salpingo-oophorectomy (RRSO) results in an 80% reduction in risk of ovarian cancer and a 50% reduction in risk of breast cancer if the surgery is performed before the onset of menopause.

Have a puzzling ob or gyn case that you'd like to share with fellow readers? We're looking for stories about intriguing diagnoses that have stumped the experts!

A form of assisted reproductive technology that could make it possible for women with mutations in mitochondrial DNA to give birth to children free of mitochondrial disease has been approved by UK’s House of Commons. A Food and Drug Administration (FDA) committee is considering granting similar approval for use of the technique-known as oocyte modification or three-parent gene therapy-in the United States.